Tango Therapeutics Inc
NASDAQ:TNGX

Watchlist Manager
Tango Therapeutics Inc Logo
Tango Therapeutics Inc
NASDAQ:TNGX
Watchlist
Price: 6.82 USD -0.87% Market Closed
Market Cap: 739.2m USD

Intrinsic Value

The intrinsic value of one TNGX stock under the Base Case scenario is 2.74 USD. Compared to the current market price of 6.82 USD, Tango Therapeutics Inc is Overvalued by 60%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TNGX Intrinsic Value
2.74 USD
Overvaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tango Therapeutics Inc

What is Valuation History?
Compare TNGX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TNGX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Tango Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tango Therapeutics Inc

Current Assets 225m
Cash & Short-Term Investments 216.7m
Other Current Assets 8.3m
Non-Current Assets 49m
PP&E 47m
Other Non-Current Assets 2m
Efficiency

Free Cash Flow Analysis
Tango Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tango Therapeutics Inc

Revenue
41m USD
Operating Expenses
-188m USD
Operating Income
-147m USD
Other Expenses
14m USD
Net Income
-133m USD
Fundamental Scores

TNGX Profitability Score
Profitability Due Diligence

Tango Therapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Net Margin is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
14/100
Profitability
Score

Tango Therapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

TNGX Solvency Score
Solvency Due Diligence

Tango Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Tango Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TNGX Price Targets Summary
Tango Therapeutics Inc

Wall Street analysts forecast TNGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNGX is 10.2 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

Lowest
Price Target
8.08 USD
18% Upside
Average
Price Target
10.2 USD
50% Upside
Highest
Price Target
13.65 USD
100% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Tango Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TNGX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TNGX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TNGX stock?

The intrinsic value of one TNGX stock under the Base Case scenario is 2.74 USD.

Is TNGX stock undervalued or overvalued?

Compared to the current market price of 6.82 USD, Tango Therapeutics Inc is Overvalued by 60%.

Back to Top